3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids
3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids
No Thumbnail Available
Files
There are no files associated with this item.
Date
2019
Authors
de Groot, Marnix HP
Zhang, Congcong
Mosa, Mohammed H.
Michels, Birgitta E.
Röder, Jasmin
Darvishi, Tahmineh
Wels, Winfried S.
Farin, Henner F.
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
DOI (citable link)
International patent number
Link to the license
oops
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published
Published in
The EMBO journal ; 38 (2019), 12. - e100928. - ISSN 0261-4189. - eISSN 1460-2075
Abstract
Immunotherapy using chimeric antigen receptor (CAR)-engineered lymphocytes has shown impressive results in leukemia. However, for solid tumors such as colorectal cancer (CRC), new preclinical models are needed that allow to test CAR-mediated cytotoxicity in a tissue-like environment. Here, we developed a platform to study CAR cell cytotoxicity against 3-dimensional (3D) patient-derived colon organoids. Luciferase-based measurement served as a quantitative read-out for target cell viability. Additionally, we set up a confocal live imaging protocol to monitor effector cell recruitment and cytolytic activity at a single organoid level. As proof of principle, we demonstrated efficient targeting in diverse organoid models using CAR-engineered NK-92 cells directed toward a ubiquitous epithelial antigen (EPCAM). Tumor antigen-specific cytotoxicity was studied with CAR-NK-92 cells targeting organoids expressing EGFRvIII, a neoantigen found in several cancers. Finally, we tested a novel CAR strategy targeting FRIZZLED receptors that show increased expression in a subgroup of CRC tumors. Here, comparative killing assays with normal organoids failed to show tumor-specific activity. Taken together, we report a sensitive in vitro platform to evaluate CAR efficacy and tumor specificity in a personalized manner.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
SCHNALZGER, Theresa, Marnix HP DE GROOT, Congcong ZHANG, Mohammed H. MOSA, Birgitta E. MICHELS, Jasmin RÖDER, Tahmineh DARVISHI, Winfried S. WELS, Henner F. FARIN, 2019. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. In: The EMBO journal. 38(12), e100928. ISSN 0261-4189. eISSN 1460-2075. Available under: doi: 10.15252/embj.2018100928BibTex
@article{Schnalzger2019-06-17model-47046, year={2019}, doi={10.15252/embj.2018100928}, title={3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids}, number={12}, volume={38}, issn={0261-4189}, journal={The EMBO journal}, author={Schnalzger, Theresa and de Groot, Marnix HP and Zhang, Congcong and Mosa, Mohammed H. and Michels, Birgitta E. and Röder, Jasmin and Darvishi, Tahmineh and Wels, Winfried S. and Farin, Henner F.}, note={Article Number: e100928} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/47046"> <dc:contributor>Farin, Henner F.</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:contributor>Schnalzger, Theresa</dc:contributor> <dc:creator>de Groot, Marnix HP</dc:creator> <dc:creator>Zhang, Congcong</dc:creator> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Schnalzger, Theresa</dc:creator> <dc:contributor>Mosa, Mohammed H.</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:abstract xml:lang="eng">Immunotherapy using chimeric antigen receptor (CAR)-engineered lymphocytes has shown impressive results in leukemia. However, for solid tumors such as colorectal cancer (CRC), new preclinical models are needed that allow to test CAR-mediated cytotoxicity in a tissue-like environment. Here, we developed a platform to study CAR cell cytotoxicity against 3-dimensional (3D) patient-derived colon organoids. Luciferase-based measurement served as a quantitative read-out for target cell viability. Additionally, we set up a confocal live imaging protocol to monitor effector cell recruitment and cytolytic activity at a single organoid level. As proof of principle, we demonstrated efficient targeting in diverse organoid models using CAR-engineered NK-92 cells directed toward a ubiquitous epithelial antigen (EPCAM). Tumor antigen-specific cytotoxicity was studied with CAR-NK-92 cells targeting organoids expressing EGFRvIII, a neoantigen found in several cancers. Finally, we tested a novel CAR strategy targeting FRIZZLED receptors that show increased expression in a subgroup of CRC tumors. Here, comparative killing assays with normal organoids failed to show tumor-specific activity. Taken together, we report a sensitive in vitro platform to evaluate CAR efficacy and tumor specificity in a personalized manner.</dcterms:abstract> <dc:creator>Farin, Henner F.</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-26T13:53:51Z</dcterms:available> <dc:contributor>de Groot, Marnix HP</dc:contributor> <dc:creator>Michels, Birgitta E.</dc:creator> <dc:contributor>Michels, Birgitta E.</dc:contributor> <dc:contributor>Zhang, Congcong</dc:contributor> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/47046"/> <dc:creator>Mosa, Mohammed H.</dc:creator> <dc:creator>Wels, Winfried S.</dc:creator> <dcterms:title>3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids</dcterms:title> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Darvishi, Tahmineh</dc:contributor> <dc:contributor>Wels, Winfried S.</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-09-26T13:53:51Z</dc:date> <dc:language>eng</dc:language> <dcterms:issued>2019-06-17</dcterms:issued> <dc:creator>Röder, Jasmin</dc:creator> <dc:contributor>Röder, Jasmin</dc:contributor> <dc:creator>Darvishi, Tahmineh</dc:creator> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Refereed
Yes